Observational Study of the HemoCept Device During Right Heart Catheterization at Boulder Heart
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.
• Subjects can be any gender but must be age 18 or older.
• Subject is able and willing to provide informed consent and HIPAA authorization.
• Subject is able and willing to meet all study requirements.
• Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible)
Locations
United States
Colorado
Boulder Heart
RECRUITING
Boulder
Contact Information
Primary
Katharine Adkins
kathari.adkins@bch.org
303-442-2395
Time Frame
Start Date: 2025-12-01
Estimated Completion Date: 2026-03-30
Participants
Target number of participants: 50
Related Therapeutic Areas
Sponsors
Leads: HemoCept Inc.